GlassScriptPhysician profile
Bridget Briscoe
NPI 1528789252
$1,135.08
in general payments reported to CMS, 2019-2025
15 companies · $887 in 2025
The $887 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $94.08 · 2024: $154 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.70 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $222.80 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $134.56 | 2023-2025 | Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $130.76 | 2025 | Dupixent |
| Genzyme Corporation | $120.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.10 | 2025 | Jascayd |
| Axsome Therapeutics, INC. | $83.36 | 2025 | Sunosi |
| Glaxosmithkline, LLC. | $72.12 | 2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $56.79 | 2024-2025 | |
| Lilly USA, LLC | $51.72 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $49.96 | 2025 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.79 | 2023-2024 | Xifaxan |
| Abbvie INC. | $28.16 | 2025 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Pfizer INC. | $16.36 | 2024 | |
| Exact Sciences Corporation | $15.22 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Briscoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.